| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V26404 | Netupitant | 290297-26-6 | Netupitant (formerly CID-6451149; AGE-94200; Ro 67-3189)is an orally bioavailable neurokinin 1 (NK1) receptor antagonist with potential antiemetic activity. |
|
V70787 | Netupitant-d6 (Netupitant D6; CID-6451149-d6) | 2070015-31-3 | Netupitant-d6 is a deuterium labelled form ofNetupitant (CID-6451149), a highly efficient, selective, orally bioactive Neurokinin-1 receptor (NK1) antagonist. |
|
V70784 | Neurokinin A TFA (Substance K TFA; Neurokinin α TFA; Neuromedin L TFA) | 2828433-19-6 | Neurokinin A TFA (Substance K TFA) is a bioactive peptide neurotransmitter of the tachykinin family that acts through the NK-2 receptor. |
|
V76709 | Neurokinin A(4-10) TFA | Neurokinin A (4-10) TFA is a tachykinin NK2 receptor agonist (activator). | |
|
V70804 | Neurokinin Receptor (393-407), rat (SPR393-407) | 153607-26-2 | Neurokinin Receptor (393-407), rat (SPR393–407) is a fragment of the rat neurokinin 1 receptor (NK1R). |
|
V70799 | NK1 receptor antagonist 2 | 579475-17-5 | NK1 receptor antagonist 2 is an NK1 receptor antagonist. |
|
V70792 | NK3R-IN-1 | 2854331-14-7 | NK3R-IN-1 (compound 16x) is an imidazopiperazine analogue and an orally bioactive Neurokinin Receptor NK3R inhibitor. |
|
V4278 | Pavinetant | 941690-55-7 | AZD2624 (also known as AZD-4901, MLE-4901, AZ-12472520, and AZD-2624) is a novel, potent, selective and orally bioactive neurokinin-3 receptor (NK3R) antagonist. |
|
V70812 | Phyllomedusin | 26145-48-2 | Phyllomedusin, a tachykinin decapeptide, is an NK1 receptor agonist (activator). |
|
V70808 | QWF Peptide | 126088-82-2 | QWF Peptide (Compound 4a) is a substance P antagonist (inhibitor) with IC50 of 0.09 μM. |
|
V3303 | Rolapitant | 552292-08-7 | Rolapitant (formerly SCH-619734; SCH619734; tradename: Varubi) is a selective,CNS penetrant and orally bioactiveneurokinin (NK1) receptor antagonist (Ki = 0.66 nM) with antiemetic activity. |
|
V3304 | Rolapitant HCl | 914462-92-3 | Rolapitant HCl (SCH619734; SCH-619734; SCH 619734; Varubi), the hydrochloride salt of Rolapitant, is a CNS penetreable and orally bioavailable antagonist of neurokinin (NK1) receptor (Ki = 0.66 nM) that was approved in 2015 to prevent delayed nausea and vomiting caused by cancer chemotherapy. |
|
V4618 | SB 222200 | 174635-69-9 | SB-222200 is a novel, potent, selective, reversible, brain penetrant and competitive antagonist of human NK-3 receptor with Ki of 4.4 nM. |
|
V76487 | Spantide I TFA | Spantide I TFA is an analogue of substance P and a selective neurokinin-1 receptor (NK1 receptor) antagonist. | |
|
V76473 | Substance P (5-11) (TFA) | Substance P (5-11) TFA TFA is the C-terminal heptapeptide of Substance P (Substance P), a neuropeptide that binds to the NK-1 tachykinin receptor. | |
|
V70794 | Substance P (6-11) | 51165-07-2 | Substance P (6-11) is the C-terminal hexapeptide amide of Substance P (Substance P). |
|
V70785 | Substance P(1-7) TFA | 2828433-22-1 | Substance P(1-7) TFA is a fragment of the neuropeptide substance P (SP). |
|
V70796 | Substance P-Gly-Lys-Arg | 123148-51-6 | Substance P-Gly-Lys-Arg, known also as β-Preprotachykinin (58-71), is an analog of Substance P (Substance P). |
|
V4357 | VAPREOTIDE | 103222-11-3 | Vapreotide (trade name: Sanvar) is a synthetic somatostatin analog and a NK1R antagonist with an IC50 of 330 nM. |
|
V4358 | VAPREOTIDE ACETATE | 849479-74-9 | Vapreotide acetate (trade name: Sanvar) is a synthetic somatostatin analog and a NK1R antagonist with an IC50 of 330 nM. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
